Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference-Reference-Cited by-同舟云学术

Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference

Published:2020-12 Issue:6 Volume:76 Page:842-850
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Edmonston Daniel L.,Roe Matthew T.,Block Geoffrey,Conway Paul T.,Dember Laura M.,DiBattiste Peter M.,Greene Tom,Hariri Ali,Inker Lesley A.,Isakova Tamara,Montez-Rath Maria E.,Nkulikiyinka Richard,Polidori David,Roessig Lothar,Tangri Navdeep,Wyatt Christina,Chertow Glenn M.,Wolf Myles

Funder

Duke Clinical Research Institute

Publisher

Elsevier BV

Subject

Nephrology

Reference52 articles.

1. Impact of recent clinical trials on nephrology practice: are we in a stagnant era?;Yaseen;Kidney Dis (Basel),2019

2. It's time to reverse our thinking: the reverse translation research paradigm;Shakhnovich;Clin Transl Sci,2018

3. Machine learning in medicine;Rajkomar;N Engl J Med,2019

4. Bidirectional data collaborations in distributed research;Haynes;EGEMS (Wash DC),2016

5. The FDA Sentinel Initiative - an evolving national resource;Platt;N Engl J Med,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Necrosis Factor-α Gene Polymorphism is Associated with Short- and Long-Term Kidney Allograft Outcomes;Journal of Inflammation Research;2022-04

2. Bioengineering Strategies to Develop Podocyte Culture Systems;Tissue Engineering Part B: Reviews;2021-12-08

3. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression;American Journal of Kidney Diseases;2021-09

4. Tumor necrosis factor-α gene polymorphism is associated with short- and long-term kidney allograft outcomes;2021-07-31